vs
Indivior Pharmaceuticals, Inc.（INDV）与朗美通（LITE）财务数据对比。点击上方公司名可切换其他公司
朗美通的季度营收约是Indivior Pharmaceuticals, Inc.的1.9倍（$665.5M vs $357.0M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 11.8%，领先17.1%），朗美通自由现金流更多（$43.1M vs $-245.0M）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
朗美通控股（Lumentum Holdings Inc.）是全球知名光电产品供应商，前身为美国捷迪讯（JDSU）旗下光电器件及激光业务板块，2015年8月随捷迪讯分拆独立运营，总部位于美国加利福尼亚州米尔皮塔斯，主营光通信网络设备、激光器、定制光学解决方案等多元产品。
INDV vs LITE — 直观对比
营收规模更大
LITE
是对方的1.9倍
$357.0M
净利率更高
INDV
高出17.1%
11.8%
自由现金流更多
LITE
多$288.1M
$-245.0M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $665.5M |
| 净利润 | $103.0M | $78.2M |
| 毛利率 | 82.1% | 36.1% |
| 营业利润率 | 22.7% | 9.7% |
| 净利率 | 28.9% | 11.8% |
| 营收同比 | — | 65.5% |
| 净利润同比 | 390.5% | 228.4% |
| 每股收益（稀释后） | $0.79 | $0.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVLITE
| Q4 25 | $357.0M | $665.5M | ||
| Q3 25 | $314.0M | $533.8M | ||
| Q2 25 | $302.0M | $480.7M | ||
| Q1 25 | $266.0M | $425.2M | ||
| Q4 24 | — | $402.2M | ||
| Q3 24 | $307.0M | $336.9M | ||
| Q2 24 | $299.0M | $308.3M | ||
| Q1 24 | — | $366.5M |
净利润INDVLITE
| Q4 25 | $103.0M | $78.2M | ||
| Q3 25 | $42.0M | $4.2M | ||
| Q2 25 | $18.0M | $213.3M | ||
| Q1 25 | $47.0M | $-44.1M | ||
| Q4 24 | — | $-60.9M | ||
| Q3 24 | $22.0M | $-82.4M | ||
| Q2 24 | $-97.0M | $-252.5M | ||
| Q1 24 | — | $-127.0M |
毛利率INDVLITE
| Q4 25 | 82.1% | 36.1% | ||
| Q3 25 | 73.2% | 34.0% | ||
| Q2 25 | 82.8% | 33.3% | ||
| Q1 25 | 83.1% | 28.8% | ||
| Q4 24 | — | 24.8% | ||
| Q3 24 | 78.5% | 23.1% | ||
| Q2 24 | 73.6% | 16.6% | ||
| Q1 24 | — | 16.2% |
营业利润率INDVLITE
| Q4 25 | 22.7% | 9.7% | ||
| Q3 25 | 13.7% | 1.3% | ||
| Q2 25 | 23.8% | -1.7% | ||
| Q1 25 | 24.8% | -8.9% | ||
| Q4 24 | — | -12.8% | ||
| Q3 24 | 11.4% | -24.5% | ||
| Q2 24 | -39.5% | -43.3% | ||
| Q1 24 | — | -31.3% |
净利率INDVLITE
| Q4 25 | 28.9% | 11.8% | ||
| Q3 25 | 13.4% | 0.8% | ||
| Q2 25 | 6.0% | 44.4% | ||
| Q1 25 | 17.7% | -10.4% | ||
| Q4 24 | — | -15.1% | ||
| Q3 24 | 7.2% | -24.5% | ||
| Q2 24 | -32.4% | -81.9% | ||
| Q1 24 | — | -34.7% |
每股收益（稀释后）INDVLITE
| Q4 25 | $0.79 | $0.89 | ||
| Q3 25 | $0.33 | $0.05 | ||
| Q2 25 | $0.14 | $3.10 | ||
| Q1 25 | $0.38 | $-0.64 | ||
| Q4 24 | — | $-0.88 | ||
| Q3 24 | $0.16 | $-1.21 | ||
| Q2 24 | $-0.72 | $-3.75 | ||
| Q1 24 | — | $-1.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $846.6M |
| 总资产 | $1.2B | $4.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVLITE
| Q4 25 | $195.0M | $1.2B | ||
| Q3 25 | $445.0M | $1.1B | ||
| Q2 25 | $510.0M | $877.1M | ||
| Q1 25 | $373.0M | $866.7M | ||
| Q4 24 | — | $896.7M | ||
| Q3 24 | — | $916.1M | ||
| Q2 24 | — | $887.0M | ||
| Q1 24 | — | $870.9M |
股东权益INDVLITE
| Q4 25 | $-98.0M | $846.6M | ||
| Q3 25 | $-207.0M | $780.8M | ||
| Q2 25 | $-257.0M | $1.1B | ||
| Q1 25 | $-285.0M | $879.5M | ||
| Q4 24 | — | $872.3M | ||
| Q3 24 | $-310.0M | $895.9M | ||
| Q2 24 | $-281.0M | $957.3M | ||
| Q1 24 | — | $1.2B |
总资产INDVLITE
| Q4 25 | $1.2B | $4.8B | ||
| Q3 25 | $1.4B | $4.6B | ||
| Q2 25 | $1.5B | $4.2B | ||
| Q1 25 | $1.4B | $4.0B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $3.9B | ||
| Q1 24 | — | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $126.7M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $43.1M |
| 自由现金流率自由现金流/营收 | -68.6% | 6.5% |
| 资本支出强度资本支出/营收 | 6.7% | 12.6% |
| 现金转化率经营现金流/净利润 | -2.15× | 1.62× |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $-29.5M |
8季度趋势，按日历期对齐
经营现金流INDVLITE
| Q4 25 | $-221.0M | $126.7M | ||
| Q3 25 | $-39.0M | $57.9M | ||
| Q2 25 | $158.0M | $64.0M | ||
| Q1 25 | $75.0M | $-1.6M | ||
| Q4 24 | — | $24.3M | ||
| Q3 24 | $2.0M | $39.6M | ||
| Q2 24 | $88.0M | $35.5M | ||
| Q1 24 | — | $-7.0M |
自由现金流INDVLITE
| Q4 25 | $-245.0M | $43.1M | ||
| Q3 25 | $-59.0M | $-18.3M | ||
| Q2 25 | $141.0M | $10.1M | ||
| Q1 25 | $70.0M | $-64.4M | ||
| Q4 24 | — | $-15.9M | ||
| Q3 24 | $-5.0M | $-34.5M | ||
| Q2 24 | $84.0M | $10.9M | ||
| Q1 24 | — | $-26.6M |
自由现金流率INDVLITE
| Q4 25 | -68.6% | 6.5% | ||
| Q3 25 | -18.8% | -3.4% | ||
| Q2 25 | 46.7% | 2.1% | ||
| Q1 25 | 26.3% | -15.1% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | -1.6% | -10.2% | ||
| Q2 24 | 28.1% | 3.5% | ||
| Q1 24 | — | -7.3% |
资本支出强度INDVLITE
| Q4 25 | 6.7% | 12.6% | ||
| Q3 25 | 6.4% | 14.3% | ||
| Q2 25 | 5.6% | 11.2% | ||
| Q1 25 | 1.9% | 14.8% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | 2.3% | 22.0% | ||
| Q2 24 | 1.3% | 8.0% | ||
| Q1 24 | — | 5.3% |
现金转化率INDVLITE
| Q4 25 | -2.15× | 1.62× | ||
| Q3 25 | -0.93× | 13.79× | ||
| Q2 25 | 8.78× | 0.30× | ||
| Q1 25 | 1.60× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
LITE
| Components | $443.7M | 67% |
| Systems | $221.8M | 33% |
